Westpac Banking Corp’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,775
Closed -$489K 692
2023
Q1
$489K Sell
20,775
-2,562
-11% -$68.8K 0.01% 746
2022
Q4
$652K Sell
23,337
-376
-2% -$9.61K 0.01% 674
2022
Q3
$555K Buy
23,713
+2,973
+14% +$89.8K 0.01% 699
2022
Q2
$700K Buy
+20,740
New +$726K 0.01% 716
2022
Q1
Sell
-1,904
Closed -$58K 842
2021
Q4
$58K Buy
+1,904
New +$62K ﹤0.01% 817
2021
Q3
Sell
-8,184
Closed -$248K 845
2021
Q2
$248K Buy
+8,184
New +$269K ﹤0.01% 842

Other funds holding OGN

Westpac Banking Corp's OGN Position: Q2 2023 in Review

Westpac Banking Corp sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 20,775 shares — an estimated $489K sold.

Westpac Banking Corp first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $700K in Q2 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Westpac Banking Corp reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Westpac Banking Corp sold 20,775 Organon & Co shares in Q2 2023, an estimated $489K.
  • Westpac Banking Corp first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Westpac Banking Corp's Organon & Co position peaked at $700K in Q2 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Westpac Banking Corp's 13F filing for Q2 2023, filed 10 Aug 2023.